BLDEW Financials
Newest figures come from the 10-Q for Q1 FY2026, filed May 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BLDEW SEC filings page.
BLDEW (BLDEW) reported $228.6M in revenue over the twelve months to Mar 31, 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Profitability returned in FY2025, but the dominant mechanic remains cash-conversion pressure amid a lightly leveraged balance sheet.
FY2025 reported net income of$41.3M while operating cash flow was-$48.9M , so the accounting profit did not translate into cash generation. Receivables also climbed from$19.8M in FY2024 to$40.0M in FY2025, pointing to cash tied up elsewhere in the operating cycle rather than a self-funding profit engine.
Revenue recovered in FY2025 while gross margin moved from
Free cash flow reached
Financial Health Signals
BLDEW does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
BLDEW passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, BLDEW used $1.18 of operating cash (-$48.9M OCF vs $41.3M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.
Key Financial Metrics
Earnings & Revenue
BLDEW generated $67.4M in revenue in Q1 2026. This represents an increase of 87.4% from the same quarter a year earlier. Against the prior quarter it is up 64.0%.
BLDEW's EBITDA was $86K in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 102.2% from the same quarter a year earlier. Against the prior quarter it is up 103.0%.
BLDEW reported $2.2M in net income in Q1 2026. This represents an increase of 161.7% from the same quarter a year earlier. Against the prior quarter it is up 124.4%.
BLDEW earned $0.03 per diluted share (EPS) in Q1 2026. This represents an increase of 175.0% from the same quarter a year earlier.
Cash & Balance Sheet
BLDEW recorded an outflow of $1.3M in free cash flow in Q1 2026, representing a cash shortfall after capex. This represents an increase of 54.8% from the same quarter a year earlier. Against the prior quarter it is up 87.3%.
BLDEW held $58.7M in cash as of Q1 2026; long-term debt is not reported for that period.
Not reported for Q1 2026.
Margins & Returns
BLDEW's gross margin was 20.9% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is up 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 9.5 percentage points.
BLDEW's operating margin was -4.4% in Q1 2026, reflecting core business profitability. This is up 11.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 10.4 percentage points.
BLDEW's net profit margin was 3.2% in Q1 2026, showing the share of revenue converted to profit. This is up 12.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 24.7 percentage points.
BLDEW's ROE was 0.8% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is up 2.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.9 percentage points.
Capital Allocation
BLDEW invested $5.2M in capex in Q1 2026, funding long-term assets and infrastructure. This represents an increase of 98.1% from the same quarter a year earlier. Against the prior quarter it is up 180.2%.
Not reported for Q1 2026.
Not reported for Q1 2026.
BLDEW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $67.4M+87.4% | $41.1M | $49.3M+36.7% | $70.8M+4.2% | $35.9M-30.2% | N/A | $36.1M-49.5% | $67.9M+11.4% |
| Cost of Revenue | $53.3M+84.3% | $36.4M | $37.7M+32.0% | $53.1M+2.9% | $28.9M-30.2% | N/A | $28.6M-48.9% | $51.6M+1.9% |
| Gross Profit | $14.1M+100.2% | $4.7M | $11.6M+54.7% | $17.7M+8.5% | $7.1M-30.4% | N/A | $7.5M-51.8% | $16.4M+57.7% |
| SG&A Expenses | $15.6M+26.6% | $12.1M | $16.3M+17.5% | $20.1M-19.9% | $12.3M-28.4% | N/A | $13.9M-28.0% | $25.1M+36.5% |
| Operating Income | -$3.0M+47.7% | -$6.1M | -$5.6M+20.7% | -$5.0M+59.2% | -$5.7M+42.4% | N/A | -$7.1M+4.8% | -$12.1M+0.5% |
| EBITDA | $86K+102.2% | -$2.8M | -$4.2M+28.1% | -$3.2M+70.0% | -$4.0M+51.8% | N/A | -$5.8M-3.7% | -$10.6M-1.8% |
| Interest Expense | N/A | N/A | N/A | $1.2M-35.4% | $1.3M-36.2% | N/A | $1.8M-17.8% | $1.8M-13.9% |
| Income Tax | $0 | -$21K | $0 | $21K-59.6% | $0+100.0% | N/A | $0-100.0% | $52K+113.8% |
| Net Income | $2.2M+161.7% | -$8.8M | $57.4M+3038.4% | -$3.7M+67.0% | -$3.5M+17.5% | N/A | -$2.0M-776.1% | -$11.3M+7.4% |
| EPS (Basic) | $0.03+175.0% | N/A | $0.70+2433.3% | -$0.05+66.7% | -$0.04+33.3% | N/A | -$0.03 | -$0.15+11.8% |
| EPS (Diluted) | $0.03+175.0% | N/A | $0.70+2433.3% | -$0.05+66.7% | -$0.04+33.3% | N/A | -$0.03 | -$0.15+11.8% |
| Diluted Shares (Avg) | 90M+12.9% | N/A | 82M+5.7% | 81M+4.8% | 80M+5.4% | N/A | 78M-3.7% | 78M+6.1% |
Not reported in any period shown, so not listed: R&D Expenses.
BLDEW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $327.6M+30.8% | $325.5M+26.8% | $335.1M+18.4% | $257.9M-8.0% | $250.6M-11.4% | $256.7M-13.0% | $282.9M-10.9% | $280.3M-12.4% |
| Current Assets | $124.1M-18.5% | $126.2M-21.5% | $122.5M-28.7% | $156.5M-14.5% | $152.3M-21.5% | $160.7M-22.1% | $171.8M-17.7% | $182.9M-12.5% |
| Cash & Equivalents | $58.7M+68.6% | $31.0M+68.5% | $22.8M+13.6% | $58.8M+123.3% | $34.8M-5.2% | $18.4M-34.1% | $20.0M-45.6% | $26.3M-29.6% |
| Accounts Receivable | $39.6M+79.0% | $40.0M+101.6% | $37.5M+53.3% | $28.2M+1.6% | $22.1M-6.0% | $19.8M-5.6% | $24.5M+16.4% | $27.7M+23.1% |
| Goodwill | $88.6M+110.7% | $88.2M+467.6% | $84.6M+97.0% | $44.3M+11.8% | $42.0M+5.7% | $15.5M+16.6% | $43.0M+9.5% | $39.6M-0.6% |
| Total Liabilities | $41.9M+35.9% | $46.4M+33.6% | $52.1M+5.3% | $34.8M-31.7% | $30.8M-33.3% | $34.7M-42.7% | $49.4M-9.5% | $50.9M-14.3% |
| Current Liabilities | $20.9M-4.3% | $19.8M-12.9% | $27.9M+2.5% | $26.3M-13.1% | $21.9M-5.9% | $22.7M-36.0% | $27.2M-10.5% | $30.3M+3.5% |
| Non-Current Liabilities | $20.9M+134.4% | $26.6M+121.5% | $24.2M+8.7% | $8.5M-58.8% | $8.9M-61.0% | $12.0M-52.2% | $22.3M-8.3% | $20.7M-31.5% |
| Total Equity | $285.7M+30.0% | $279.1M+25.7% | $283.0M+21.2% | $223.1M-2.7% | $219.7M-7.1% | $221.9M-5.3% | $233.5M-11.2% | $229.4M-12.0% |
| Retained Earnings | -$143.4M+24.7% | -$145.6M+22.1% | -$136.7M+22.8% | -$194.1M-10.8% | -$190.4M-16.1% | -$186.9M-17.0% | -$177.1M-40.8% | -$175.2M-38.9% |
Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Long-Term Investments, Long-Term Debt.
BLDEW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.9M+1679.3% | -$8.3M-374.1% | -$37.3M-686.9% | -$3.1M-136.4% | -$246K+98.4% | -$1.8M+81.2% | $6.4M+214.1% | $8.4M+202.8% |
| Depreciation & Amortization | $3.1M+80.3% | $3.3M | $1.4M+13.0% | $1.8M+13.9% | $1.7M+6.5% | N/A | $1.3M-30.6% | $1.6M-13.9% |
| Stock-Based Compensation | $5.0M+19.4% | N/A | N/A | N/A | $4.2M-2.3% | N/A | $5.3M+60.5% | $5.5M+98.3% |
| Capital Expenditures | $5.2M+98.1% | $1.8M-59.6% | $2.8M-69.6% | $2.3M-85.7% | $2.6M+220.3% | $4.6M+18966.7% | $9.3M+1239.1% | $16.2M+2072.4% |
| Free Cash Flow | -$1.3M+54.8% | -$10.2M-60.5% | -$40.1M-1259.3% | -$5.4M+30.6% | -$2.9M+82.5% | -$6.3M+32.3% | -$3.0M-322.3% | -$7.7M+13.5% |
| Investing Cash Flow | $24.7M+21.2% | $18.3M+359.4% | $2.4M+119.0% | $28.7M+269.6% | $20.4M-16.9% | $4.0M+5201.3% | -$12.6M-316.7% | -$16.9M-548.0% |
| Financing Cash Flow | -$859K+79.8% | -$1.7M+55.0% | -$1.8M-144.5% | -$1.1M+5.9% | -$4.2M-7963.0% | -$3.9M-16743.5% | -$731K-12083.3% | -$1.2M-5940.0% |
| Share Buybacks | N/A | $0 | $0 | N/A | N/A | $0 | $0 | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
BLDEW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 20.9%+1.3pp | 11.5% | 23.6%+2.7pp | 25.1%+1.0pp | 19.6%-0.1pp | N/A | 20.8%-1.0pp | 24.1%+7.1pp |
| Operating Margin | -4.4%+11.4pp | -14.8% | -11.4%+8.3pp | -7.0%+10.9pp | -15.8%+3.4pp | N/A | -19.7%-9.2pp | -17.9%+2.1pp |
| Net Margin | 3.2%+12.9pp | -21.5% | 116.5% | -5.3%+11.4pp | -9.7%-1.5pp | N/A | -5.4%-5.8pp | -16.7%+3.4pp |
| Return on Equity | 0.8%+2.3pp | -3.2% | 20.3%+21.1pp | -1.7%+3.3pp | -1.6%+0.2pp | N/A | -0.8%-0.9pp | -4.9%-0.3pp |
| Return on Assets | 0.7%+2.0pp | -2.7% | 17.1%+17.8pp | -1.5%+2.6pp | -1.4%+0.1pp | N/A | -0.7%-0.8pp | -4.0%-0.2pp |
| Current Ratio | 5.93-1.0x | 6.38-0.7x | 4.39-1.9x | 5.95-0.1x | 6.96-1.4x | 7.07+1.3x | 6.32-0.6x | 6.04-1.1x |
| Debt-to-Equity | 0.150.0x | 0.170.0x | 0.180.0x | 0.16-0.1x | 0.14-0.1x | 0.16-0.1x | 0.210.0x | 0.220.0x |
| Asset Turnover | 0.21+0.1x | 0.13 | 0.150.0x | 0.270.0x | 0.140.0x | N/A | 0.13-0.1x | 0.24+0.1x |
| FCF Margin | -1.9%+6.0pp | -24.7% | -81.4%-73.2pp | -7.6%+3.8pp | -8.0%+23.8pp | N/A | -8.2%-10.1pp | -11.4%+3.3pp |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Where BLDEW Ranks
Frequently Asked Questions
What is BLDEW's annual revenue?
BLDEW (BLDEW) reported $197.1M in total revenue for fiscal year 2025. This represents a 34.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is BLDEW's revenue growing?
BLDEW (BLDEW) revenue grew by 34.3% year-over-year, from $146.8M to $197.1M in fiscal year 2025.
Is BLDEW profitable?
Yes, BLDEW (BLDEW) reported a net income of $41.3M in fiscal year 2025, with a net profit margin of 21.0%.
What is BLDEW's EBITDA?
BLDEW (BLDEW) had EBITDA of -$14.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is BLDEW's gross margin?
BLDEW (BLDEW) had a gross margin of 20.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is BLDEW's operating margin?
BLDEW (BLDEW) had an operating margin of -11.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is BLDEW's net profit margin?
BLDEW (BLDEW) had a net profit margin of 21.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is BLDEW's return on equity (ROE)?
BLDEW (BLDEW) has a return on equity of 14.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is BLDEW's free cash flow?
BLDEW (BLDEW) recorded an outflow of $58.5M in free cash flow during fiscal year 2025. This represents a -75.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is BLDEW's operating cash flow?
BLDEW (BLDEW) recorded an outflow of $48.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are BLDEW's total assets?
BLDEW (BLDEW) had $325.5M in total assets as of fiscal year 2025, including both current and long-term assets.
What are BLDEW's capital expenditures?
BLDEW (BLDEW) invested $9.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is BLDEW's current ratio?
BLDEW (BLDEW) had a current ratio of 6.38 as of fiscal year 2025, which is generally considered healthy.
What is BLDEW's debt-to-equity ratio?
BLDEW (BLDEW) had a debt-to-equity ratio of 0.17 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is BLDEW's return on assets (ROA)?
BLDEW (BLDEW) had a return on assets of 12.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is BLDEW's Piotroski F-Score?
BLDEW (BLDEW) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are BLDEW's earnings high quality?
For every $1 of reported earnings, BLDEW (BLDEW) used $1.18 of operating cash (-$48.9M OCF vs $41.3M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.